Apexigen, Inc. Operating Cash Flow
Apexigen, Inc. reported Operating Cash Flow of -$9.76 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-08-10
- Apexigen, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$3.00M.
- Apexigen, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$6.76M.
- Apexigen, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$3.05M.
- Apexigen, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$13.50M.
- Apexigen, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$30.69M.
- Apexigen, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$23.90M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$9.76M 10-Q · filed 2023-08-10 | -$12.82M derived: sum of 3 quarters · filed 2023-08-10 | -$26.31M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2023-03-31 | -$6.76M 10-Q · filed 2023-05-15 | -$9.81M derived: sum of 2 quarters · filed 2023-05-15 | -$23.31M derived: sum of 3 quarters · filed 2023-05-15 | -$29.11M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-12-31 | -$3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$16.55M derived: sum of 2 quarters · filed 2023-02-22 | -$22.35M derived: sum of 3 quarters · filed 2023-08-10 | -$30.69M 10-K · filed 2023-02-22 | ||||||
| 2022-09-30 | -$13.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$19.30M derived: sum of 2 quarters · filed 2023-08-10 | -$27.64M 10-Q · filed 2022-11-14 | -$32.79M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-06-30 | -$5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$14.14M 10-Q · filed 2023-08-10 | -$415.44K 10-Q · filed 2022-08-18 | -$19.29M derived: sum of 3 quarters · filed 2023-08-10 | -$37.73M derived: sum of 4 quarters · filed 2023-08-10 | |||||
| 2022-03-31 | -$8.34M 10-Q · filed 2023-05-15 | -$124.09K 10-Q · filed 2022-05-23 | -$13.49M derived: sum of 2 quarters · filed 2023-05-15 | -$31.93M derived: sum of 3 quarters · filed 2023-05-15 | -$31.99M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | -$5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$23.59M derived: sum of 2 quarters · filed 2023-02-22 | -$23.65M derived: sum of 3 quarters · filed 2023-02-22 | -$23.90M 10-K · filed 2023-02-22 | -$451.53K 10-K · filed 2022-04-07 | |||||
| 2021-09-30 | -$18.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$18.51M derived: sum of 2 quarters · filed 2022-11-14 | -$18.75M 10-Q · filed 2022-11-14 | -$394.44K 10-Q · filed 2021-12-09 | ||||||
| 2021-06-30 | -$68.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-18 | -$316.80K 10-Q · filed 2022-08-18 | ||||||||
| 2021-03-31 | -$247.91K 10-Q · filed 2022-05-23 | |||||||||
| 2020-09-30 | $0.00 10-Q · filed 2021-12-09 | |||||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |